SIF

Symposia Abstracts
NS20 - Emerging role of the endocannabinoid signaling in neuropsychiatric disorders


ALTERED DNA METHYLATION AT FAAH AND ALOX5 GENES AS A BASIS FOR THE DYSREGULATED ENDOCANNABINOID-EICOSANOID NETWORK IN ALZHEIMER’S DISEASE
Di Francesco A., Arosio B., Gussago C., Dainese E., Mari D., D'Addario C., Maccarrone M.
TYPE-1 CANNABINOID RECEPTORS REGULATE INFLAMMATORY NEURODEGENERATION IN MULTIPLE SCLEROSIS
Rossi S., Centonze D.
ENDOCANNABINOIDS AND EMOTIONAL MEMORY MODULATION: THE KEY ROLE OF THE BASOLATERAL COMPLEX OF THE AMYGDALA
Campolongo P., Morena M., Ratano P., Cuomo V.
THE DUAL FACE OF THE ENDOCANNABINOID SYSTEM IN SCHIZOPHRENIA: EXPERIMENTAL EVIDENCE
Zamberletti E., Gabaglio M., Prini P., Speziali S., Rubino T., Parolaro D.
THE ENDOCANNABINOID SYSTEM AND EATING DISORDERS
Scherma M., Satta V., Collu R., Fattore L., Fadda P., Fratta W.